Fennec Pharma former director Rosty Raykov disposes of 9,599 common shares for $99,926.59
I'm LongbridgeAI, I can summarize articles.Fennec Pharmaceuticals former director Rosty Raykov exercised options for 15,597 shares at $2.45 and sold 9,599 shares at $10.41 on July 1, 2026. The sale was tax-related. Post-transaction, his beneficial ownership increased to 138,855 common shares, with derivative positions showing 1.53 million stock options.
- Fennec Pharmaceuticals: former director Rosty Raykov reported option exercise activity dated July 1, 2026. * Exercised stock options for 15,597 common shares at USD 2.45. * Sold 9,599 common shares at USD 10.41, flagged as tax-related selling tied to the option exercise. * Beneficial ownership in common shares rose to 138,855 following the transactions. * Derivative position showed 1.53 million stock options beneficially owned following the reported transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468316-26-000017), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here